Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey V Moiseev

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|April 12, 2022
Identification and Quantification by NMR Spectroscopy of the 22<i>R</i> and 22<i>S</i> Epimers in Budesonide Pharmaceutical FormsNatalia E Kuz'mina, Sergey V Moiseev, Elena Y Severinova, et al.
Rheumatology International|October 27, 2014
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experiencePavel I Novikov, Sergey V Moiseev, Ekaterina I Kuznetsova, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Tofacitinib in steroid-dependent relapsing polychondritisAlexey D Meshkov, Pavel I Novikov, Evgeny V Zhilyaev, et al.
Rheumatology International|January 15, 2015
Predictors of AA amyloidosis in familial Mediterranean feverNikolay A Mukhin, Lidiya V Kozlovskaya, Marina V Bogdanova, et al.
Nephrology (Carlton, Vic.)|October 21, 2023
A pilot study of anti-nephrin antibodies in podocytopaties among adultsNatalia Chebotareva, Anatoliy Vinogradov, Yevgeniya Birukova, et al.
Antiviral Therapy|January 26, 2019
Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistanceDzhamal T Abdurakhmanov, Teona P Rozina, Elena N Nikulkina, et al.
Antiviral Therapy|September 29, 2018
Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistanceDzhamal T Abdurakhmanov, Teona P Rozina, Elena N Nikulkina, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experienceEkaterina A Nabatchikova, Dzhamal T Abdurakhmanov, Teona P Rozina, et al.
Rheumatology (Oxford, England)|July 17, 2018
Certolizumab pegol in the treatment of Takayasu arteritisPavel I Novikov, Ilya O Smitienko, Maria V Sokolova, et al.
Frontiers in Nephrology|November 15, 2024
Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathiesNatalia V Chebotareva, Evgeniya A Charionovskaya, Evgenia A Biryukova, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|April 12, 2022
Identification and Quantification by NMR Spectroscopy of the 22<i>R</i> and 22<i>S</i> Epimers in Budesonide Pharmaceutical FormsNatalia E Kuz'mina, Sergey V Moiseev, Elena Y Severinova, et al.
Rheumatology International|October 27, 2014
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experiencePavel I Novikov, Sergey V Moiseev, Ekaterina I Kuznetsova, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Tofacitinib in steroid-dependent relapsing polychondritisAlexey D Meshkov, Pavel I Novikov, Evgeny V Zhilyaev, et al.
Rheumatology International|January 15, 2015
Predictors of AA amyloidosis in familial Mediterranean feverNikolay A Mukhin, Lidiya V Kozlovskaya, Marina V Bogdanova, et al.
Nephrology (Carlton, Vic.)|October 21, 2023
A pilot study of anti-nephrin antibodies in podocytopaties among adultsNatalia Chebotareva, Anatoliy Vinogradov, Yevgeniya Birukova, et al.
Antiviral Therapy|January 26, 2019
Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistanceDzhamal T Abdurakhmanov, Teona P Rozina, Elena N Nikulkina, et al.
Antiviral Therapy|September 29, 2018
Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistanceDzhamal T Abdurakhmanov, Teona P Rozina, Elena N Nikulkina, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experienceEkaterina A Nabatchikova, Dzhamal T Abdurakhmanov, Teona P Rozina, et al.
Rheumatology (Oxford, England)|July 17, 2018
Certolizumab pegol in the treatment of Takayasu arteritisPavel I Novikov, Ilya O Smitienko, Maria V Sokolova, et al.
Frontiers in Nephrology|November 15, 2024
Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathiesNatalia V Chebotareva, Evgeniya A Charionovskaya, Evgenia A Biryukova, et al.
Pageof 3